IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS

Acute Lymphoblastic Leukemia (ALL) is the most common neoplasm in pediatric age. In recent years, between 15 and 20% of patients failed in their treatments. Knowledge on cytogenetics and molecular biology has an important impact on the determination of the prognosis and the appropriate treatment sch...

Full description

Bibliographic Details
Main Authors: Y.C. Castro, R. Utrera
Format: Article
Language:English
Published: Sociedad Argentina de Genética 2020-07-01
Series:BAG. Journal of Basic and Applied Genetics
Subjects:
Online Access:https://sag.org.ar/jbag/wp-content/uploads/2020/07/v31n1a04.pdf
_version_ 1818609847119118336
author Y.C. Castro
R. Utrera
author_facet Y.C. Castro
R. Utrera
author_sort Y.C. Castro
collection DOAJ
description Acute Lymphoblastic Leukemia (ALL) is the most common neoplasm in pediatric age. In recent years, between 15 and 20% of patients failed in their treatments. Knowledge on cytogenetics and molecular biology has an important impact on the determination of the prognosis and the appropriate treatment scheme. In Venezuela there is limited knowledge regarding the molecular genetics of this onco-hematological alteration. The aim of this work was to evaluate the most frequent genetic alterations in Venezuelan patients with a clinical diagnosis of acute lymphoblastic leukemia. A cross-sectional, descriptive and prospective study was carried out from 2006 to 2014, in which the translocations ETV6/RUNX1, MLL/AF4, TCF3/PBX1, BCR/ABL1, as well as mutations in the PAX5 and FLT3 genes were evaluated through the use of different types of PCR. One hundred and thirty patients with a clinical diagnosis of acute lymphocytic leukemia were included in the study. Molecular alterations were identified in 56 patients (43.1%), in which we observed the presence of one or several alterations in conjunction in the same patient. The alterations identified were t(12; 21) (11.5%), t(4; 11) (8.5%), t(1; 19) (10%), t(9; 22) (20.8%), ITD-FLT3 (14.8%), P80S mutation (4.2%) and S77del (4.2%) in the PAX5 gene. The prevalence of BCR/ABL is one of the highest described so far in cases of ALL where most of the population is made up of pediatric patients. These results represent the first molecular study of ALL in Venezuela, laying the foundations for the diagnosis and monitoring of the disease in its population.
first_indexed 2024-12-16T15:05:02Z
format Article
id doaj.art-d073ff6e54ba4afdb88685891b4a1e23
institution Directory Open Access Journal
issn 1852-6233
language English
last_indexed 2024-12-16T15:05:02Z
publishDate 2020-07-01
publisher Sociedad Argentina de Genética
record_format Article
series BAG. Journal of Basic and Applied Genetics
spelling doaj.art-d073ff6e54ba4afdb88685891b4a1e232022-12-21T22:27:10ZengSociedad Argentina de GenéticaBAG. Journal of Basic and Applied Genetics1852-62332020-07-01311334310.35407/bag.2020.31.01.04IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSISY.C. Castro 0R. Utrera 1Laboratorio Genética Molecular Humana, Universidad Simón Bolívar, Venezuela.Laboratorio Genética Molecular Humana, Universidad Simón Bolívar, Venezuela.Acute Lymphoblastic Leukemia (ALL) is the most common neoplasm in pediatric age. In recent years, between 15 and 20% of patients failed in their treatments. Knowledge on cytogenetics and molecular biology has an important impact on the determination of the prognosis and the appropriate treatment scheme. In Venezuela there is limited knowledge regarding the molecular genetics of this onco-hematological alteration. The aim of this work was to evaluate the most frequent genetic alterations in Venezuelan patients with a clinical diagnosis of acute lymphoblastic leukemia. A cross-sectional, descriptive and prospective study was carried out from 2006 to 2014, in which the translocations ETV6/RUNX1, MLL/AF4, TCF3/PBX1, BCR/ABL1, as well as mutations in the PAX5 and FLT3 genes were evaluated through the use of different types of PCR. One hundred and thirty patients with a clinical diagnosis of acute lymphocytic leukemia were included in the study. Molecular alterations were identified in 56 patients (43.1%), in which we observed the presence of one or several alterations in conjunction in the same patient. The alterations identified were t(12; 21) (11.5%), t(4; 11) (8.5%), t(1; 19) (10%), t(9; 22) (20.8%), ITD-FLT3 (14.8%), P80S mutation (4.2%) and S77del (4.2%) in the PAX5 gene. The prevalence of BCR/ABL is one of the highest described so far in cases of ALL where most of the population is made up of pediatric patients. These results represent the first molecular study of ALL in Venezuela, laying the foundations for the diagnosis and monitoring of the disease in its population.https://sag.org.ar/jbag/wp-content/uploads/2020/07/v31n1a04.pdfacute lymphoblastic leukemiatranslocationsetv6/runx1mll/af4tcf3/pbx1bcr/abl1pax5flt3
spellingShingle Y.C. Castro
R. Utrera
IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
BAG. Journal of Basic and Applied Genetics
acute lymphoblastic leukemia
translocations
etv6/runx1
mll/af4
tcf3/pbx1
bcr/abl1
pax5
flt3
title IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
title_full IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
title_fullStr IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
title_full_unstemmed IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
title_short IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
title_sort identification of molecular alterations in venezuelan patients with acute lymphoblastic leukemia diagnosis
topic acute lymphoblastic leukemia
translocations
etv6/runx1
mll/af4
tcf3/pbx1
bcr/abl1
pax5
flt3
url https://sag.org.ar/jbag/wp-content/uploads/2020/07/v31n1a04.pdf
work_keys_str_mv AT yccastro identificationofmolecularalterationsinvenezuelanpatientswithacutelymphoblasticleukemiadiagnosis
AT rutrera identificationofmolecularalterationsinvenezuelanpatientswithacutelymphoblasticleukemiadiagnosis